CRMD
Price
$4.16
Change
+$0.05 (+1.22%)
Updated
Mar 27, 6:59 PM EST
46 days until earnings call
VTVT
Price
$24.43
Change
+$0.63 (+2.65%)
Updated
Mar 28, 8:31 AM EST
Ad is loading...

Compare predictions CRMD vs VTVT

Header iconCRMD vs VTVT Comparison
Open Charts CRMD vs VTVTBanner chart's image
CorMedix
Price$4.16
Change+$0.05 (+1.22%)
Volume$236.17K
CapitalizationN/A
vTv Therapeutics
Price$24.43
Change+$0.63 (+2.65%)
Volume$100
CapitalizationN/A
View a ticker or compare two or three
CRMD vs VTVT Comparison Chart

Loading...

CRMDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VTVTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CRMD vs. VTVT commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMD is a StrongBuy and VTVT is a Hold.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (CRMD: $4.17 vs. VTVT: $23.09)
Brand notoriety: CRMD and VTVT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRMD: 77% vs. VTVT: 24%
Market capitalization -- CRMD: $229.27M vs. VTVT: $56.17M
CRMD [@Biotechnology] is valued at $229.27M. VTVT’s [@Biotechnology] market capitalization is $56.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $576.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRMD’s FA Score shows that 0 FA rating(s) are green whileVTVT’s FA Score has 0 green FA rating(s).

  • CRMD’s FA Score: 0 green, 5 red.
  • VTVT’s FA Score: 0 green, 5 red.
According to our system of comparison, both CRMD and VTVT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRMD’s TA Score shows that 5 TA indicator(s) are bullish while VTVT’s TA Score has 6 bullish TA indicator(s).

  • CRMD’s TA Score: 5 bullish, 4 bearish.
  • VTVT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VTVT is a better buy in the short-term than CRMD.

Price Growth

CRMD (@Biotechnology) experienced а +9.74% price change this week, while VTVT (@Biotechnology) price change was -13.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.41%. For the same industry, the average monthly price growth was +5.97%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

CRMD is expected to report earnings on May 13, 2024.

VTVT is expected to report earnings on Feb 28, 2024.

Industries' Descriptions

@Biotechnology (+4.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CRMD with price predictions.
OPEN
A.I.dvisor published
a Summary for VTVT with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CRMD($229M) has a higher market cap than VTVT($56.2M). VTVT YTD gains are higher at: 100.783 vs. CRMD (10.904). VTVT has higher annual earnings (EBITDA): -25.86M vs. CRMD (-46.23M). CRMD has more cash in the bank: 76M vs. VTVT (9.45M). VTVT has less debt than CRMD: VTVT (529K) vs CRMD (668K). CRMD (0) and VTVT (0) have equivalent revenues.
CRMDVTVTCRMD / VTVT
Capitalization229M56.2M407%
EBITDA-46.23M-25.86M179%
Gain YTD10.904100.78311%
P/E RatioN/AN/A-
Revenue00-
Total Cash76M9.45M805%
Total Debt668K529K126%
FUNDAMENTALS RATINGS
CRMD vs VTVT: Fundamental Ratings
CRMD
VTVT
OUTLOOK RATING
1..100
2032
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
4234
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTVT's Valuation (92) in the Biotechnology industry is in the same range as CRMD (95) in the Medical Specialties industry. This means that VTVT’s stock grew similarly to CRMD’s over the last 12 months.

VTVT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CRMD (100) in the Medical Specialties industry. This means that VTVT’s stock grew similarly to CRMD’s over the last 12 months.

CRMD's SMR Rating (98) in the Medical Specialties industry is in the same range as VTVT (100) in the Biotechnology industry. This means that CRMD’s stock grew similarly to VTVT’s over the last 12 months.

VTVT's Price Growth Rating (34) in the Biotechnology industry is in the same range as CRMD (42) in the Medical Specialties industry. This means that VTVT’s stock grew similarly to CRMD’s over the last 12 months.

VTVT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CRMD (100) in the Medical Specialties industry. This means that VTVT’s stock grew similarly to CRMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRMDVTVT
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 3 days ago
87%
Declines
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 24 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
CRMDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VTVTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GE180.126.57
+3.79%
General Electric Company
MCFT22.830.83
+3.77%
MasterCraft Boat Holdings
BB2.750.09
+3.38%
BlackBerry Limited
NSPR2.280.03
+1.40%
InspireMD
BEP23.150.28
+1.22%
Brookfield Renewable Partners LP

CRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRMD has been loosely correlated with BMRN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CRMD jumps, then BMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRMD
1D Price
Change %
CRMD100%
+1.46%
BMRN - CRMD
38%
Loosely correlated
+1.01%
XERS - CRMD
36%
Loosely correlated
-0.49%
ALNY - CRMD
36%
Loosely correlated
+1.55%
ZVRA - CRMD
35%
Loosely correlated
+4.02%
BEAM - CRMD
35%
Loosely correlated
+2.35%
More

VTVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTVT has been loosely correlated with VANI. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if VTVT jumps, then VANI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTVT
1D Price
Change %
VTVT100%
N/A
VANI - VTVT
55%
Loosely correlated
-1.60%
ADIL - VTVT
29%
Poorly correlated
+1.10%
MNOV - VTVT
25%
Poorly correlated
+8.09%
IMNN - VTVT
25%
Poorly correlated
+19.75%
ONTX - VTVT
25%
Poorly correlated
+7.78%
More